Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siegfried Janz

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Optics Letters|September 16, 2015
High-directionality fiber-chip grating coupler with interleaved trenches and subwavelength index-matching structureDaniel Benedikovic, Carlos Alonso-Ramos, Pavel Cheben, et al.
The Journal of Clinical Investigation|June 1, 2021
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignanciesCan Li, Jiliang Xia, Reinaldo Franqui-Machin, et al.
Cancer Research|March 1, 2005
Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in miceSung Sup Park, Joong Su Kim, Lino Tessarollo, et al.
Bone Marrow Transplantation|December 22, 2022
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapySamer Al Hadidi, Aniko Szabo, Jean Esselmann, et al.
Journal of the National Cancer Institute|August 14, 2019
Identification and Characterization of Tumor-Initiating Cells in Multiple MyelomaMinjie Gao, Hua Bai, Yogesh Jethava, et al.
Haematologica|August 30, 2023
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myelomaLindsay Hammons, Aniko Szabo, Abhishek Janardan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 14, 2025
Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC PathwayZhi Wen, Yidan Wang, Kathryn C Fox, et al.
Journal of Hematology & Oncology|June 29, 2023
A gene signature can predict risk of MGUS progressing to multiple myelomaFumou Sun, Yan Cheng, Jun Ying, et al.
American Journal of Hematology|September 13, 2022
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experienceMeera Mohan, Lisa E Rein, Nishanth Thalambedu, et al.
Nature Communications|January 19, 2024
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growthFumou Sun, Yan Cheng, Visanu Wanchai, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Optics Letters|September 16, 2015
High-directionality fiber-chip grating coupler with interleaved trenches and subwavelength index-matching structureDaniel Benedikovic, Carlos Alonso-Ramos, Pavel Cheben, et al.
The Journal of Clinical Investigation|June 1, 2021
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignanciesCan Li, Jiliang Xia, Reinaldo Franqui-Machin, et al.
Cancer Research|March 1, 2005
Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in miceSung Sup Park, Joong Su Kim, Lino Tessarollo, et al.
Bone Marrow Transplantation|December 22, 2022
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapySamer Al Hadidi, Aniko Szabo, Jean Esselmann, et al.
Journal of the National Cancer Institute|August 14, 2019
Identification and Characterization of Tumor-Initiating Cells in Multiple MyelomaMinjie Gao, Hua Bai, Yogesh Jethava, et al.
Haematologica|August 30, 2023
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myelomaLindsay Hammons, Aniko Szabo, Abhishek Janardan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 14, 2025
Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC PathwayZhi Wen, Yidan Wang, Kathryn C Fox, et al.
Journal of Hematology & Oncology|June 29, 2023
A gene signature can predict risk of MGUS progressing to multiple myelomaFumou Sun, Yan Cheng, Jun Ying, et al.
American Journal of Hematology|September 13, 2022
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experienceMeera Mohan, Lisa E Rein, Nishanth Thalambedu, et al.
Nature Communications|January 19, 2024
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growthFumou Sun, Yan Cheng, Visanu Wanchai, et al.
Pageof 16